Literature DB >> 7340444

Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons.

A Denjean, B Arnoux, J Benveniste, A Lockhart, R Masse.   

Abstract

Intratracheal administration of PAF-acether (60 microgram.kg-1) was performed in six premedicated, curarized and mechanically ventilated baboons. Whereas intratracheal administration of an equal amount of solvent (200 microliter of 80 degrees alcohol in 2 ml of saline) caused no measurable changes in lung mechanics, administration of PAF-acether caused an almost immediate bronchoconstriction that was spontaneously reversible within about 30 min. The concomitant fall in platelet count in peripheral blood and reduction of perfusion of ventilated lung territories estimated from the alveolar-arterial difference in CO2 tension provide circumstantial evidence that PAF-acether also caused aggregation of platelets in the lung microcirculation. In keeping with the release of PAF-acether by human alveolar macrophages, our findings suggest that this mediator may play a role in human asthma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7340444     DOI: 10.1007/bf01978743

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  5 in total

1.  The role of platelet-activating factor in platelet aggregation.

Authors:  M Chignard; J P Le Couedic; M Tence; B B Vargaftig; J Benveniste
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

2.  Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis.

Authors:  B Arnoux; D Duval; J Benveniste
Journal:  Eur J Clin Invest       Date:  1980-12       Impact factor: 4.686

3.  [Arterio-alveolar difference in CO2 (AaDCO2) : measurement, interpretation, clinical value].

Authors:  H Guenard; A Denjean; M Chaussain; J de Lattre; B Gamain
Journal:  Poumon Coeur       Date:  1978

4.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

5.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

  5 in total
  5 in total

1.  Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.

Authors:  N M Roberts; M McCusker; K F Chung; P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

2.  Inhibition of Paf-acether-induced edema of the rat's paw.

Authors:  K F Swingle; M J Reiter
Journal:  Agents Actions       Date:  1986-06

Review 3.  Platelet-activating factor (PAF-acether): present status.

Authors:  J Benveniste
Journal:  Agents Actions       Date:  1981-12

Review 4.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

Review 5.  Platelet activating factor as a mediator and therapeutic approach in bronchial asthma.

Authors:  A Kasperska-Zajac; Z Brzoza; B Rogala
Journal:  Inflammation       Date:  2008-01-12       Impact factor: 4.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.